95 related articles for article (PubMed ID: 1775269)
21. Plasma kinetics of 125I-labelled amyloid P component in beta 2M amyloidosis: a possible approach to quantitate disease activity.
Zingraff J; Caillat-Vigneron N; Ureña P; Gagné ER; Bererhi L; Moretti JL; Bardin T; Drüeke TB
Nephrol Dial Transplant; 1995; 10(2):223-9. PubMed ID: 7753457
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of beta 2-microglobulin in lymphocyte culture: role of hemodialysis, dialysis membranes, dialysis-amyloidosis, and lymphokines.
Campistol JM; Molina R; Bernard DB; Rodriguez R; Mirapeix E; Munoz-Gomez JM; Revert L
Am J Kidney Dis; 1993 Nov; 22(5):691-9. PubMed ID: 8238015
[TBL] [Abstract][Full Text] [Related]
23. Serum alpha 2-macroglobulin in haemodialysis patients: baseline and kinetic studies.
Argilés A; Kerr PG; Mourad G; Mion CM; Atkins RC
Nephrol Dial Transplant; 1993; 8(10):1118-23. PubMed ID: 7505905
[TBL] [Abstract][Full Text] [Related]
24. Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis.
Iida Y; Miyata T; Inagi R; Sugiyama S; Maeda K
Biochem Biophys Res Commun; 1994 Jun; 201(3):1235-41. PubMed ID: 8024566
[TBL] [Abstract][Full Text] [Related]
25. Red blood cell function and beta 2 microglobulin kinetics during cuprophan hemodialysis: a hypothesis.
Lins RL; Zachée P; Daelemans R; Vanden Broecke E; Boogaerts MA; De Broe ME
Int J Artif Organs; 1989 Oct; 12(10):638-41. PubMed ID: 2509378
[TBL] [Abstract][Full Text] [Related]
26. Detection of novel beta 2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition.
Ogawa H; Saito A; Oda O; Nakajima M; Chung TG
Clin Nephrol; 1988 Sep; 30(3):158-63. PubMed ID: 3052955
[TBL] [Abstract][Full Text] [Related]
27. [What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis?].
Assounga A; Canaud B; Flavier JL; Slingeneyer A; Robinet-Lévy M; Aznar R; Mion C
Nephrologie; 1987; 8(6):301-6. PubMed ID: 3330579
[TBL] [Abstract][Full Text] [Related]
28. Serum low-molecular-weight proteins in haemodialysis patients: effect of residual renal function.
Brown PH; Kalra PA; Turney JH; Cooper EH
Nephrol Dial Transplant; 1988; 3(2):169-73. PubMed ID: 2459634
[TBL] [Abstract][Full Text] [Related]
29. Effects of Hemophan and Cuprophan dialysis on beta-2 microglobulin levels, exercise capacity, and symptoms scores.
Tomson CV; Woffindin C; Sheldon W; Hoenich NA
Nephrol Dial Transplant; 1988; 3(3):355-6. PubMed ID: 3140115
[No Abstract] [Full Text] [Related]
30. Enhanced beta 2-microglobulin levels in lymphocyte culture supernatants from patients with idiopathic nephrotic syndrome: inhibition of lymphocyte activation by cyclosporine.
Robeva R; Heslan JM; Branellec A; Laurent J; Lagrue G
Clin Nephrol; 1988 Oct; 30(4):211-5. PubMed ID: 3063418
[TBL] [Abstract][Full Text] [Related]
31. Suppression of immunoglobulin and interleukin-6 production from peripheral blood mononuclear cells by dialysis membranes.
Paczek L; Schafer RM; Teschner M; Heidland A
ASAIO Trans; 1990; 36(3):459-61. PubMed ID: 2252806
[TBL] [Abstract][Full Text] [Related]
32. Stimulation of beta 2-microglobulin synthesis in lymphocytes after exposure to Cuprophan dialyzer membranes.
Jahn B; Betz M; Deppisch R; Janssen O; Hänsch GM; Ritz E
Kidney Int; 1991 Aug; 40(2):285-90. PubMed ID: 1942777
[TBL] [Abstract][Full Text] [Related]
33. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
[TBL] [Abstract][Full Text] [Related]
34. Long-term variations of serum beta 2-microglobulin levels in hemodialysed uremics according to permeability and bioincompatibility of dialysis membranes.
Simon P; Cavarle YY; Ang KS; Cam G; Catheline M
Blood Purif; 1988; 6(2):111-6. PubMed ID: 3293614
[TBL] [Abstract][Full Text] [Related]
35. Hemodialysis-related induction of beta-2-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes.
Knudsen PJ; Leon J; Ng AK; Shaldon S; Floege J; Koch KM
Nephron; 1989; 53(3):188-93. PubMed ID: 2507949
[TBL] [Abstract][Full Text] [Related]
36. Circulating form of beta-2-microglobulin in dialysis patients.
Gagnon RF; Somerville P; Thomson DM
Am J Nephrol; 1988; 8(5):379-83. PubMed ID: 3071144
[TBL] [Abstract][Full Text] [Related]
37. Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells.
Memoli B; Libetta C; Rampino T; Dal Canton A; Conte G; Scala G; Ruocco MR; Andreucci VE
Kidney Int; 1992 Aug; 42(2):320-6. PubMed ID: 1405316
[TBL] [Abstract][Full Text] [Related]
38. Beta 2-microglobulin serum levels during dialysis: effect of cuprophan and serum osmolality changes.
Sulková S; Votruba T; Lapcík O; Válek A
Int J Artif Organs; 1990 Jan; 13(1):22-5. PubMed ID: 2203684
[TBL] [Abstract][Full Text] [Related]
39. Extracorporeal blood recirculation and beta-2-microglobulin plasma levels during hemodialysis.
Di Giulio S; Splendiani G; Sturniolo A; Costanzi S; Barini A; Passalacqua S; Barbera G; Cervelli V; Cipriani G; Adorno D
ASAIO Trans; 1988; 34(3):185-7. PubMed ID: 3058172
[TBL] [Abstract][Full Text] [Related]
40. Long-term clinical evaluation of an adsorbent column (BM-01) of direct hemoperfusion type for beta 2-microglobulin on the treatment of dialysis-related amyloidosis.
Gejyo F; Teramura T; Ei I; Arakawa M; Nakazawa R; Azuma N; Suzuki M; Furuyoshi S; Nankou T; Takata S
Artif Organs; 1995 Dec; 19(12):1222-6. PubMed ID: 8967878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
